Cargando…
Antiviral agents for the treatment of COVID-19: Progress and challenges
The COVID-19 pandemic has seen clinical development and use of antiviral therapies at an unprecedented speed. Antiviral therapies have greatly improved the clinical outcome in COVID-19 patients, especially when administered early after diagnosis. Here, we discuss the successes and challenges of COVI...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831133/ https://www.ncbi.nlm.nih.gov/pubmed/35474740 http://dx.doi.org/10.1016/j.xcrm.2022.100549 |